Boxer Capital, LLC Ptc Therapeutics, Inc. Transaction History

Boxer Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $32.2 Million - $50.1 Million	-1,000,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$28.09 - $39.49 $32.4 Million - $45.6 Million	-1,155,000 Reduced 53.6%	1,000,000 $37.6 Million
Q3 2018 Nov 14, 2018	BUY	$33.9 - $47.77 $8.64 Million - $12.2 Million	255,000 Added 13.42%	2,155,000 $101 Million
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $18 Million - $33.5 Million	-700,000 Reduced 26.92%	1,900,000 $64.1 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $14.8 Million - $27.7 Million	850,000 Added 48.57%	2,600,000 $70.2 Million
Q4 2017 Feb 14, 2018	BUY	$15.14 - $20.89 $7.57 Million - $10.4 Million	500,000 Added 40.0%	1,750,000 $29.2 Million
Q3 2017 Nov 14, 2017	BUY	$16.81 - $21.61 $21 Million - $27 Million	1,250,000	1,250,000 $25 Million

215

79.2M

122K

212K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.69B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.